Authorisation application submitted for the COVID-19 vaccine from Novavax
Bern, 14.2.2022 - Future Health Pharma GmbH has submitted an authorisation application to Swissmedic for vaccine candidate Nuvaxovid from Novavax. This is the first protein-based vaccine for which an authorisation application has been submitted in Switzerland.